Prevention of relapse after allogeneic hematopoietic cell transplantation by donor and cell source selection

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Bone Marrow Transplantation

• Publication date

  2018-05-24

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/s41409-018-0218-1PMID 29795435PMCID PMC7286200
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Optimal Practices in Unrelated Donor Cord Blood Transplantation for Hematologic Malignancies.

  2017cited by this paper
• Current Use and Trends in Hematopoietic Cell Transplantation in the United States.

  2017cited by this paper
• Alloreactivity: the Janus-face of hematopoietic stem cell transplantation

  2017cited by this paper
• Current Use and Trends in Hematopoietic Cell Transplantation in the United States.

  2017cited by this paper
• KIR3DL1/HLA-B Subtypes Govern Acute Myelogenous Leukemia Relapse After Hematopoietic Cell Transplantation.

  2017cited by this paper
• Selective graft-versus-leukemia depends on magnitude and diversity of the alloreactive T cell response

  2017cited by this paper
• Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation.

  2017cited by this paper
• Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report

  2017cited by this paper
• In celebration of Ruggero Ceppellini: HLA in transplantation

  2017cited by this paper
• Cord-Blood Transplantation in Patients with Minimal Residual Disease.

  2016cited by this paper
• Cell-Extrinsic MHC Class I Molecule Engagement Augments Human NK Cell Education Programmed by Cell-Intrinsic MHC Class I.

  2016cited by this paper
• Haploidentical Hematopoietic Stem Cell Transplantation: A Global Overview Comparing Asia, the European Union, and the United States.

  2016cited by this paper
• Defining KIR and HLA Class I Genotypes at Highest Resolution via High-Throughput Sequencing.

  2016cited by this paper
• Modern approaches to HLA-haploidentical blood or marrow transplantation

  2016cited by this paper
• Comparable outcomes with marrow or peripheral blood as stem cell sources for hematopoietic cell transplantation from haploidentical donors after non-ablative conditioning: a matched-pair analysis

  2016cited by this paper
• Killer cell immunoglobulin-like receptor 3DL1 polymorphism defines distinct hierarchies of HLA class I recognition

  2016cited by this paper
• Open conformers of HLA-F are high-affinity ligands of the activating NK-cell receptor KIR3DS1

  2016cited by this paper
• KIR3DL1 and HLA-B Density and Binding Calibrate NK Education and Response to HIV

  2016cited by this paper
• Matched unrelated donor transplants-State of the art in the 21st century.

  2016cited by this paper
• Functional distance between recipient and donor HLA-DPB1 determines nonpermissive mismatches in unrelated HCT.

  2016cited by this paper
• Autosomal Minor Histocompatibility Antigens: How Genetic Variants Create Diversity in Immune Targets

  2016cited by this paper
• The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy.

  2016cited by this paper
• Specific removal of alloreactive T-cells to prevent GvHD in hemopoietic stem cell transplantation: rationale, strategies and perspectives.

  2016cited by this paper
• High-Resolution Match Rate of 7/8 and 9/10 or Better for the Be The Match Unrelated Donor Registry.

  2016cited by this paper
• Umbilical cord blood cells from unrelated donor as an alternative source of hematopoietic stem cells for transplantation in children and adults.

  2016cited by this paper
• HLA mismatching as a strategy to reduce relapse after alternative donor transplantation.

  2016cited by this paper
• Cord-Blood Transplantation in Patients with Minimal Residual Disease.

  2016cited by this paper
• Indiscernible Benefit of Double-Unit Umbilical Cord Blood Transplantation in Children: A Single-Center Experience from Hong Kong

  2016cited by this paper
• Phase II Study of Haploidentical Natural Killer Cell Infusion for Treatment of Relapsed or Persistent Myeloid Malignancies Following Allogeneic Hematopoietic Cell Transplantation.

  2016cited by this paper
• Selecting the best haploidentical donor.

  2016cited by this paper
• The impact of amino acid variability on alloreactivity defines a functional distance predictive of permissive HLA-DPB1 mismatches in hematopoietic stem cell transplantation.

  2015cited by this paper
• Comparison of unrelated cord blood and peripheral blood stem cell transplantation in adults with myelodysplastic syndrome after reduced-intensity conditioning regimen: a collaborative study from Eurocord (Cord blood Committee of Cellular Therapy & Immunobiology Working Party of EBMT) and Chronic Mal

  2015cited by this paper
• Influence of Stem Cell Source on Outcomes of Allogeneic Reduced-Intensity Conditioning Therapy Transplants Using Haploidentical Related Donors.

  2015cited by this paper
• Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality.

  2015cited by this paper
• High HLA-DP Expression and Graft-versus-Host Disease.

  2015cited by this paper
• Outcomes of acute leukemia patients transplanted with naive T cell-depleted stem cell grafts.

  2015cited by this paper
• Comparison of bone marrow versus peripheral blood allogeneic hematopoietic stem cell transplantation for hematological malignancies in adults - a systematic review and meta-analysis.

  2015cited by this paper
• Allo‐reactive T cells for the treatment of hematological malignancies

  2015cited by this paper
• Biological significance of HLA locus matching in unrelated donor bone marrow transplantation.

  2015cited by this paper
• Minor histocompatibility antigens: past, present, and future.

  2014cited by this paper
• Alternative donor hematopoietic stem cell transplantation for mature lymphoid malignancies after reduced-intensity conditioning regimen: similar outcomes with umbilical cord blood and unrelated donor peripheral blood

  2014cited by this paper
• HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry.

  2014cited by this paper
• Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation.

  2014cited by this paper
• The IPD and IMGT/HLA database: allele variant databases

  2014cited by this paper
• Development of a Novel Multiplex PCR Assay to Detect Functional Subtypes of KIR3DL1 Alleles

  2014cited by this paper
• Unrelated umbilical cord blood transplant for adult acute lymphoblastic leukemia in first and second complete remission: a comparison with allografts from adult unrelated donors

  2014cited by this paper
• Comparison of outcomes after single or double cord blood transplantation in adults with acute leukemia using different types of myeloablative conditioning regimen, a retrospective study on behalf of Eurocord and the Acute Leukemia Working Party of EBMT

  2014cited by this paper
• Donor Killer Cell Ig-like Receptor B Haplotypes, Recipient HLA-C1, and HLA-C Mismatch Enhance the Clinical Benefit of Unrelated Transplantation for Acute Myelogenous Leukemia

  2014cited by this paper
• Unrelated donor transplantation: peripheral blood or bone marrow--does it matter?

  2014cited by this paper
• Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation.

  2014cited by this paper
• One-unit versus two-unit cord-blood transplantation for hematologic cancers.

  2014cited by this paper
• Bone marrow compared with peripheral blood stem cells for haploidentical transplantation with a nonmyeloablative conditioning regimen and post-transplantation cyclophosphamide.

  2014cited by this paper
• HLA-C expression levels define permissible mismatches in hematopoietic cell transplantation.

  2014cited by this paper
• Characterization of various blood and graft sources: a prospective series

  2013cited by this paper
• Origin and biology of the allogeneic response.

  2013cited by this paper
• High-resolution HLA matching in hematopoietic stem cell transplantation: a retrospective collaborative analysis.

  2013cited by this paper
• KIR typing by non-sequencing methods: polymerase-chain reaction with sequence-specific primers.

  2012cited by this paper
• Copy number variation leads to considerable diversity for B but not A haplotypes of the human KIR genes encoding NK cell receptors

  2012cited by this paper
• Mobilized peripheral blood stem cells compared with bone marrow from HLA‐identical siblings for reduced‐intensity conditioning transplantation in acute myeloid leukemia in complete remission: a retrospective analysis from the Acute Leukemia Working Party of EBMT

  2012cited by this paper
• Peripheral-blood stem cells versus bone marrow from unrelated donors.

  2012cited by this paper
• Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study.

  2012cited by this paper
• HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1.

  2012cited by this paper
• Variable NK Cell Receptors Exemplified by Human KIR3DL1/S1

  2011cited by this paper
• Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantation.

  2010cited by this paper
• Reduced-intensity conditioning transplantation in acute leukemia: the effect of source of unrelated donor stem cells on outcomes.

  2010cited by this paper
• Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia.

  2010cited by this paper
• Stem Cell Transplantation

  2010cited by this paper
• Education of human natural killer cells by activating killer cell immunoglobulin-like receptors.

  2010cited by this paper
• Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis.

  2010cited by this paper
• Reduced mortality after allogeneic hematopoietic-cell transplantation.

  2010cited by this paper
• Unrelated umbilical cord blood transplantation and unrelated bone marrow transplantation in children with hematological disease: A meta‐analysis

  2009cited by this paper
• Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia.

  2009cited by this paper
• Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units.

  2009cited by this paper
• Decision analysis of peripheral blood versus bone marrow hematopoietic stem cells for allogeneic hematopoietic cell transplantation.

  2009cited by this paper
• Breaking tolerance to self, circulating natural killer cells expressing inhibitory KIR for non-self HLA exhibit effector function after T cell-depleted allogeneic hematopoietic cell transplantation.

  2009cited by this paper
• Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation.

  2009cited by this paper
• T-cell allorecognition: a case of mistaken identity or déjà vu?

  2008cited by this paper
• High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation.

  2007cited by this paper
• Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT.

  2007cited by this paper
• The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantation.

  2007cited by this paper
• KIR2DS1-Positive NK Cells Mediate Alloresponse against the C2 HLA-KIR Ligand Group In Vitro1

  2007cited by this paper
• Allorecognition and the alloresponse: clinical implications.

  2007cited by this paper
• Hierarchy of the Human Natural Killer Cell Response Is Determined by Class and Quantity of Inhibitory Receptors for Self-HLA-B and HLA-C Ligands1

  2007cited by this paper
• Human NK cell education by inhibitory receptors for MHC class I.

  2006cited by this paper
• Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value.

  2006cited by this paper
• KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy.

  2006cited by this paper
• The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry.

  2006cited by this paper
• A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules.

  2005cited by this paper
• Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes.

  2005cited by this paper
• Licensing of natural killer cells by host major histocompatibility complex class I molecules

  2005cited by this paper
• Inhibitory killer Ig-like receptor genes and human leukocyte antigen class I ligands in haematopoietic stem cell transplantation.

  2004cited by this paper
• A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation.

  2003cited by this paper
• Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors.

  2003cited by this paper
• CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation

  2003cited by this paper
• Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic Transplants

  2002cited by this paper
• Killer Ig-Like Receptor Haplotype Analysis by Gene Content: Evidence for Genomic Diversity with a Minimum of Six Basic Framework Haplotypes, Each with Multiple Subsets1

  2002cited by this paper
• Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation.

  1999cited by this paper
• Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation

  1997cited by this paper
• Human diversity in killer cell inhibitory receptor genes.

  1997cited by this paper
• Comparison of the content and subpopulations of CD3 and CD34 positive cells in bone marrow harvests and G-CSF-mobilized peripheral blood leukapheresis products from healthy adult donors.

  1996cited by this paper

• Differential Alloreactivity: Lessons Learned From a Singular HLA Locus

  2025cites this paper
• Pretransplant hepatomegaly is linked to relapse in patients with leukemia and myelodysplastic syndrome not in remission

  2024cites this paper
• Differential Effect of Graft-versus-Host Disease on Survival in Acute Leukemia according to Donor Type

  2021cites this paper
• Inflammation-induced tissue damage mimicking GvHD in human skin models as test-platform for immunotherapeutics.

  2020cites this paper
• Interactive Web Application for Plotting Personalized Prognosis Prediction Curves in Allogeneic Hematopoietic Cell Transplantation Using Machine Learning

  2019cites this paper
• Patient‐based prediction algorithm of relapse after allo‐HSCT for acute Leukemia and its usefulness in the decision‐making process using a machine learning approach

  2019cites this paper
• Granulocyte Colony-Stimulating Factor-Primed Unmanipulated Haploidentical Blood and Marrow Transplantation

  2019cites this paper
• Donor selection in a pediatric stem cell transplantation cohort using PIRCHE and HLA‐DPB1 typing

  2019cites this paper
• Strategies for Enhancing and Preserving Anti-leukemia Effects Without Aggravating Graft-Versus-Host Disease

  2018cites this paper